Clinical Trials Logo

Knee Pain Chronic clinical trials

View clinical trials related to Knee Pain Chronic.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06239805 Completed - Knee Pain Chronic Clinical Trials

Quantum Molecular Resonance (QMR) Rehabiltative Treatment of Knee Osteoarthritis

QMR
Start date: February 14, 2023
Phase: N/A
Study type: Interventional

Gonarthrosis (osteoarthritis of the knee (OA) is a chronic-degenerative disease, characterized by progressive joint damage up to disability that affects about 40% of people over 65 years of age. Its typical pathological changes, articular cartilage degradation, synovial inflammation and subchondral bone thickening, are responsible for the pain and disability of patients. It is now known that "biophysical stimulation" techniques represent a non-invasive therapy used in orthopedic practice to enhance the reparative and anabolic activities of the tissues through an anti-inflammatory and chondro-protective effect.The aim of the study will be to evaluate the anti-inflammatory effects and the relative mechanisms of action of the therapeutic interventions of the QMR technology (Molecular Quantum Resonance) in the treatment of gonarthrosis through the use of in vivo and in vitro models. This technology, supplied by Telea Electronic Engineering s.r.l., exploits non-ionizing high-frequency waves in the range between 4 and 64 MHz at low intensity delivered through alternating electric fields. For the in vivo study, a double-blind randomized controlled clinical trial will be conducted. Both male and female subjects, aged between 40 and 80 years, with knee pain both in the acute and chronic phase of gonarthosis, diagnosed on standard radiography, will be enrolled. Patients will be randomized into 2 groups treated with an intensive or extensive protocol, and a third untreated control group. They will be evaluated at T0 (before treatment), at T1 (end of QMR treatment), and at T2 (one month after the end of treatment (follow-up)). All patients will be assessed for pain and functionality, furthermore synovial fluid and blood sampling will be performed, for the quantitative assessment of the inflammatory state considering the levels of the main pro-inflammatory cytokines and the pro/anti-inflammatory macrophage phenotype. In parallel, in order to delineate the molecular and cellular mechanism of action of QMR stimulation in vitro, a monocyte cell model (THP-1 cell line) will be used to evaluate the response of QMR treatment after treatment with known pro-inflammatory stimuli .

NCT ID: NCT06086483 Completed - Knee Osteoarthritis Clinical Trials

Pain Management After Adductor Canal Block for Total Knee Arthroplasty

Start date: June 18, 2020
Phase: Phase 4
Study type: Interventional

This randomized, double-blinded, placebo-controlled trial sought to evaluate the efficacy of the iPACK block with Adductor Canal Block on postoperative pain, functional recovery and NLR and PLR levels.

NCT ID: NCT06060678 Completed - Knee Pain Chronic Clinical Trials

Efficacy of Genicular Nerve Alcohol Neurolysis in Knee Osteoarthritis Pain

Start date: May 9, 2023
Phase:
Study type: Observational

This study aimed to evaluate the efficacy of genicular nerve alcohol neurolysis in the treatment of pain caused by chronic knee osteoarthritis. The investigators will evaluate the efficacy of genicular nerve alcohol neurolysis using the numeric rating scale (NRS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). NRS and WOMAC scores will be evaluated before, 1, and 3 months after the procedure.

NCT ID: NCT06049303 Completed - Knee Pain Chronic Clinical Trials

Paraffin Wax Bath With Joint Mobilization Technique in Post-traumatic Stiff Knee

Start date: September 25, 2023
Phase: N/A
Study type: Interventional

This project will be a Randomized clinical trial conducted to check the effect of paraffin wax bath with joint mobilization technique in rehabilitation of post-traumatic stiff knee joint. Study duration will be of 8 months, convenient sampling was done, subject following eligibility criteria from Jinnah Hospital Lahore, will be randomly allocated in two groups, baseline assessment was done, Group A participants were given baseline treatment along with paraffin wax bath therapy and Maitland knee joint mobilization, Group B participants will be given baseline treatment along with Maitland knee joint mobilization. Assessments will done in 4th week and 8th week via, Numeric pain rating scale, goniometer, western Ontario and McMaster universities osteoarthritis index,4 sessions per week will given, data will analyzed by using SPSS version 25.

NCT ID: NCT05999266 Completed - Clinical trials for Rheumatoid Arthritis

The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis

Start date: September 28, 2023
Phase:
Study type: Observational [Patient Registry]

The knee pain status of the patients who are followed in the rheumatology special branch of the Physical Medicine and Rehabilitation Outpatient Clinic and who meet the inclusion criteria will be questioned. In patients with or without knee pain, the cartilage thickness measurement of the knee joint will be measured from 3 points by ultrasound. At the same time, Quadriceps and Hamstring muscle thickness measurements of the patients will be made from the midpoints where the muscle thickness is the highest. The physician who performed the ultrasonographic measurements of the knee pain status of the patients does not know.

NCT ID: NCT05975879 Completed - Osteoarthritis Clinical Trials

A Study of the Feasibility of Using the Dietary Supplement "ARTNEO" in Patients With Osteoathritis

Start date: May 31, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical study is to evaluate the effectiveness of the properties that support the functional state of the joints and the safety of the dietary supplement for food ARTNEO®, oral capsules, in patients with stage II-III primary osteoarthritis of the knee joint. The main questions it aims to answer are: 1. To evaluate the effectiveness of the joint functional state-supporting properties of dietary supplement ARTNEO®, capsules for oral administration, in patients with stage II-III primary osteoarthritis of the knee joint; 2. To evaluate the safety of dietary supplement ARTNEO®, capsules for oral administration, in patients with stage II-III primary osteoarthritis of the knee joint. Participants will be randomly distributed equally among two groups: - Group 1 "ARTNEO" (106 people): patients take the study dietary supplement ARTNEO®, 1 capsule 1 time per day for 6 months; - Group 2 "Placebo" (106 people): patients take placebo 1 capsule 1 time per day for 6 months.

NCT ID: NCT05871112 Completed - Knee Osteoarthritis Clinical Trials

Femoral Rotation and Patellar Positioning After TKA

Start date: January 4, 2021
Phase:
Study type: Observational

Analysis of patellar positioning in the trochlear groove after TKA with and without the use of dynamic tensioner.

NCT ID: NCT05347602 Completed - Clinical trials for Rheumatoid Arthritis

Gold Factor on Knee Joint Health and Function

Start date: August 3, 2020
Phase: N/A
Study type: Interventional

The purpose of this clinical study was to determine whether gold nanoparticles (AuNP) supplement holds clinical value in improving joint health, function, and quality of life for arthritis patients.

NCT ID: NCT05073887 Completed - Knee Pain Chronic Clinical Trials

A Comparison of Ultrasound Guided Genicular Nerve Blockade Using Current Versus Revised Anatomical Targets

Start date: March 10, 2021
Phase: N/A
Study type: Interventional

comparison of effectiveness of ultrasound guided genicular nerve blockades and radio frequency stimulation

NCT ID: NCT05045651 Completed - Clinical trials for Osteo Arthritis Knee

Anterior Knee Pain Between Unisex Knee Prosthesis VS Gender Specific Knee Prosthesis Following MIS TKA

Start date: August 1, 2014
Phase: N/A
Study type: Interventional

Unisex knee prosthesis and patient specific knee prosthesis has the same anterior knee pain and patellar tracking